astragaloside a has been researched along with cytochrome c-t in 3 studies
| Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) | Studies (cytochrome c-t) | Trials (cytochrome c-t) | Recent Studies (post-2010) (cytochrome c-t) |
|---|---|---|---|---|---|
| 675 | 5 | 573 | 11,809 | 21 | 5,125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, J; Dai, Z; Jia, Y; Li, Z; Liu, H; Pang, L; Wu, Y; Zuo, D | 1 |
| Hu, H; Jia, N; Jin, H; Sun, Q; Wang, W; Xu, J | 1 |
| Chen, X; He, H; He, M; Luo, Y; Wan, Q; Xu, M; Yin, D; Zhou, Q | 1 |
3 other study(ies) available for astragaloside a and cytochrome c-t
| Article | Year |
|---|---|
Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K/Akt pathway.
Topics: Adenosine Triphosphate; Animals; Apoptosis; bcl-Associated Death Protein; Cells, Cultured; Creatine Kinase, Mitochondrial Form; Cytochromes c; Doxorubicin; L-Lactate Dehydrogenase; Mitochondria; Mitochondrial Proton-Translocating ATPases; Myocytes, Cardiac; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Reactive Oxygen Species; Saponins; Succinate Dehydrogenase; Triterpenes | 2014 |
Protective effects of astragaloside IV against amyloid beta1-42 neurotoxicity by inhibiting the mitochondrial permeability transition pore opening.
Topics: Amyloid beta-Peptides; Apoptosis; bcl-2-Associated X Protein; Cell Line, Tumor; Cytochromes c; Humans; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Neurons; Neuroprotective Agents; Neurotoxins; Peptide Fragments; Protein Conformation; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Saponins; Superoxides; Triterpenes | 2014 |
Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
Topics: Animals; Antioxidants; Apoptosis; Biphenyl Compounds; Caspase 3; Cell Line; Cell Survival; Cytochromes c; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Saponins; Sulfonamides; Superoxide Dismutase; Triterpenes | 2019 |